Certolizumab-pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: clinical and radiographic 48-weeks results of the investigator-initiated randomized NORDSTAR trial.

Mikkel Østergaard; R Van Vollenhoven; Anna Rudin; Merete Lund Hetland; D. Nordström; Michael Nurmohamed; B. Gudbjørnsson; Lykke Midtbøll Ørnbjerg; Pernille Bøyesen; I Olsen; Kristina Lend; K Hørslev-Petersen; T Uhlig; Tuulikki Sokka-Isler; Gerdur Gröndal; Simon Krabbe; Joakim Lindqvist; Inger Gjertsson; Daniel Erik Glinatsi; Meliha C Kapetanovic; Anna-Birgitte Aga; Francesca Faustini; Pinja Parmanne; T Lorenzen; Giovanni Cagnotto; Johan Back; Oliver Hendricks; Daisy Vedder; Tuomas Rannio; Emma Grenholm; Hanne Merete Lindegaard; Maud-Kristine Aga Ljosa; Elisabeth Brodin; A Soderbergh; Milad Rizk; E Hermansson; Line Uhrenholt; Per Larsson; Søren Andreas Just; G Bakland; D. Stevens; TB Laurberg; E.A. Haavardsholm; Jon Lampa

Certolizumab-pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: clinical and radiographic 48-weeks results of the investigator-initiated randomized NORDSTAR trial.

Mikkel Østergaard, R Van Vollenhoven, Anna Rudin, Merete Lund Hetland, D. Nordström, Michael Nurmohamed, B. Gudbjørnsson, Lykke Midtbøll Ørnbjerg, Pernille Bøyesen, I Olsen, Kristina Lend, K Hørslev-Petersen, T Uhlig, Tuulikki Sokka-Isler, Gerdur Gröndal, Simon Krabbe, Joakim Lindqvist, Inger Gjertsson, Daniel Erik Glinatsi, Meliha C KapetanovicAnna-Birgitte Aga, Francesca Faustini, Pinja Parmanne, T Lorenzen, Giovanni Cagnotto, Johan Back, Oliver Hendricks, Daisy Vedder, Tuomas Rannio, Emma Grenholm, Hanne Merete Lindegaard, Maud-Kristine Aga Ljosa, Elisabeth Brodin, A Soderbergh, Milad Rizk, E Hermansson, Line Uhrenholt, Per Larsson, Søren Andreas Just, G Bakland, D. Stevens, TB Laurberg, E.A. Haavardsholm, Jon Lampa

Department for Rheumatology and Spine Diseases

Original language	English
Publication date	2022
Publication status	Published - 2022
Event	EULAR 2022 - Copenhagen Duration: 1 Jun 2022 → 4 Jun 2022

Conference

Conference	EULAR 2022
City	Copenhagen
Period	01/06/2022 → 04/06/2022

Cite this

Østergaard, M., Van Vollenhoven, R., Rudin, A., Hetland, M. L., Nordström, D., Nurmohamed, M., Gudbjørnsson, B., Ørnbjerg, L. M., Bøyesen, P., Olsen, I., Lend, K., Hørslev-Petersen, K., Uhlig, T., Sokka-Isler, T., Gröndal, G., Krabbe, S., Lindqvist, J., Gjertsson, I., Glinatsi, D. E., ... Lampa, J. (2022). Certolizumab-pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: clinical and radiographic 48-weeks results of the investigator-initiated randomized NORDSTAR trial.. Annals of the Rheumatic Diseases 81 Suppl 1: 38. Abstract from EULAR 2022, Copenhagen.

Certolizumab-pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: clinical and radiographic 48-weeks results of the investigator-initiated randomized NORDSTAR trial. / Østergaard, Mikkel; Van Vollenhoven, R; Rudin, Anna et al.
2022. Annals of the Rheumatic Diseases 81 Suppl 1: 38 Abstract from EULAR 2022, Copenhagen.

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Østergaard, M, Van Vollenhoven, R, Rudin, A, Hetland, ML, Nordström, D, Nurmohamed, M, Gudbjørnsson, B, Ørnbjerg, LM, Bøyesen, P, Olsen, I, Lend, K, Hørslev-Petersen, K, Uhlig, T, Sokka-Isler, T, Gröndal, G, Krabbe, S, Lindqvist, J, Gjertsson, I, Glinatsi, DE, Kapetanovic, MC, Aga, A-B, Faustini, F, Parmanne, P, Lorenzen, T, Cagnotto, G, Back, J, Hendricks, O, Vedder, D, Rannio, T, Grenholm, E, Lindegaard, HM, Ljosa, M-KA, Brodin, E, Soderbergh, A, Rizk, M, Hermansson, E, Uhrenholt, L, Larsson, P, Just, SA, Bakland, G, Stevens, D, Laurberg, TB, Haavardsholm, EA & Lampa, J 2022, 'Certolizumab-pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: clinical and radiographic 48-weeks results of the investigator-initiated randomized NORDSTAR trial.', EULAR 2022, Copenhagen, 01/06/2022 - 04/06/2022 pp. Annals of the Rheumatic Diseases 81 Suppl 1: 38.

@conference{138452c73ddb41a99f35b915c70d3f6d,

title = "Certolizumab-pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: clinical and radiographic 48-weeks results of the investigator-initiated randomized NORDSTAR trial.",

author = "Mikkel {\O}stergaard and {Van Vollenhoven}, R and Anna Rudin and Hetland, {Merete Lund} and D. Nordstr{\"o}m and Michael Nurmohamed and B. Gudbj{\o}rnsson and {\O}rnbjerg, {Lykke Midtb{\o}ll} and Pernille B{\o}yesen and I Olsen and Kristina Lend and K H{\o}rslev-Petersen and T Uhlig and Tuulikki Sokka-Isler and Gerdur Gr{\"o}ndal and Simon Krabbe and Joakim Lindqvist and Inger Gjertsson and Glinatsi, {Daniel Erik} and Kapetanovic, {Meliha C} and Anna-Birgitte Aga and Francesca Faustini and Pinja Parmanne and T Lorenzen and Giovanni Cagnotto and Johan Back and Oliver Hendricks and Daisy Vedder and Tuomas Rannio and Emma Grenholm and Lindegaard, {Hanne Merete} and Ljosa, {Maud-Kristine Aga} and Elisabeth Brodin and A Soderbergh and Milad Rizk and E Hermansson and Line Uhrenholt and Per Larsson and Just, {S{\o}ren Andreas} and G Bakland and D. Stevens and TB Laurberg and E.A. Haavardsholm and Jon Lampa",

note = "COPECARE; EULAR 2022 ; Conference date: 01-06-2022 Through 04-06-2022",

year = "2022",

language = "English",

pages = "Annals of the Rheumatic Diseases 81 Suppl 1: 38",

}

TY - ABST

T1 - Certolizumab-pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: clinical and radiographic 48-weeks results of the investigator-initiated randomized NORDSTAR trial.

AU - Østergaard, Mikkel

AU - Van Vollenhoven, R

AU - Rudin, Anna

AU - Hetland, Merete Lund

AU - Nordström, D.

AU - Nurmohamed, Michael

AU - Gudbjørnsson, B.

AU - Ørnbjerg, Lykke Midtbøll

AU - Bøyesen, Pernille

AU - Olsen, I

AU - Lend, Kristina

AU - Hørslev-Petersen, K

AU - Uhlig, T

AU - Sokka-Isler, Tuulikki

AU - Gröndal, Gerdur

AU - Krabbe, Simon

AU - Lindqvist, Joakim

AU - Gjertsson, Inger

AU - Glinatsi, Daniel Erik

AU - Kapetanovic, Meliha C

AU - Aga, Anna-Birgitte

AU - Faustini, Francesca

AU - Parmanne, Pinja

AU - Lorenzen, T

AU - Cagnotto, Giovanni

AU - Back, Johan

AU - Hendricks, Oliver

AU - Vedder, Daisy

AU - Rannio, Tuomas

AU - Grenholm, Emma

AU - Lindegaard, Hanne Merete

AU - Ljosa, Maud-Kristine Aga

AU - Brodin, Elisabeth

AU - Soderbergh, A

AU - Rizk, Milad

AU - Hermansson, E

AU - Uhrenholt, Line

AU - Larsson, Per

AU - Just, Søren Andreas

AU - Bakland, G

AU - Stevens, D.

AU - Laurberg, TB

AU - Haavardsholm, E.A.

AU - Lampa, Jon

N1 - COPECARE

PY - 2022

Y1 - 2022

M3 - Conference abstract for conference

SP - Annals of the Rheumatic Diseases 81 Suppl 1: 38

T2 - EULAR 2022

Y2 - 1 June 2022 through 4 June 2022

ER -